These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35675680)

  • 1. Sex as an Independent Risk Factor for Venous Thromboembolism in Sickle Cell Disease: A Cross-Sectional Study.
    Roe AH; McAllister A; Kete C; Pishko A; Whitworth H; Schreiber CA; Sayani FA
    J Womens Health (Larchmt); 2022 Oct; 31(10):1467-1471. PubMed ID: 35675680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors for venous thromboembolism in children with sickle cell disease: an administrative database study.
    Kumar R; Stanek J; Creary S; Dunn A; O'Brien SH
    Blood Adv; 2018 Feb; 2(3):285-291. PubMed ID: 29431623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism incidence in the Cooperative Study of Sickle Cell Disease.
    Naik RP; Streiff MB; Haywood C; Segal JB; Lanzkron S
    J Thromb Haemost; 2014 Dec; 12(12):2010-6. PubMed ID: 25280124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of venous thromboembolism in patients with sickle cell disease undergoing noncardiovascular surgery.
    Osei SK; Long GW; Sharrak A; Derias N; Goodson R; Callahan RE; Studzinski DM; Brown OW
    J Vasc Surg Venous Lymphat Disord; 2023 May; 11(3):543-552. PubMed ID: 36574902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous Thromboembolism in Children with Sickle Cell Disease: A Retrospective Cohort Study.
    Woods GM; Sharma R; Creary S; O'Brien S; Stanek J; Hor K; Young J; Dunn AL; Kumar R
    J Pediatr; 2018 Jun; 197():186-190.e1. PubMed ID: 29605397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.
    Okoye HC; Ezekekwu C; Nwagha TU; Korubo K; Omunakwe HE; Nnachi OC; Madu AJ; Nwogoh B; Efobi CC; Muoghalu EA; Nonyelu C; Okoye AE; Obodo OI; Ugwu CS; Egolum MC; Nnachi OA; Okpala I
    Eur J Haematol; 2022 Oct; 109(4):321-326. PubMed ID: 35687045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thromboembolism in pregnant women with sickle cell disease: a retrospective database analysis.
    Seaman CD; Yabes J; Li J; Moore CG; Ragni MV
    Thromb Res; 2014 Dec; 134(6):1249-52. PubMed ID: 25306185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
    Brunson A; Lei A; Rosenberg AS; White RH; Keegan T; Wun T
    Br J Haematol; 2017 Jul; 178(2):319-326. PubMed ID: 28369826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High incidence of venous thromboembolism recurrence in patients with sickle cell disease.
    Brunson A; Keegan T; Mahajan A; White R; Wun T
    Am J Hematol; 2019 Aug; 94(8):862-870. PubMed ID: 31074115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for venous thromboembolism in adults with hemoglobin SC or Sβ(+) thalassemia genotypes.
    Yu TT; Nelson J; Streiff MB; Lanzkron S; Naik RP
    Thromb Res; 2016 May; 141():35-8. PubMed ID: 26962984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and venous thromboembolism risk in patients with sickle cell disease.
    Singh A; Brandow AM; Wun T; Shet AS
    Blood Adv; 2022 Aug; 6(15):4408-4412. PubMed ID: 35763429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know.
    Naik RP; Streiff MB; Lanzkron S
    J Thromb Thrombolysis; 2013 Apr; 35(3):352-8. PubMed ID: 23435703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming challenges of venous thromboembolism in sickle cell disease treatment.
    Ogunsile FJ; Naik R; Lanzkron S
    Expert Rev Hematol; 2019 Mar; 12(3):173-182. PubMed ID: 30773073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Venous thromboembolism in adults with sickle cell disease: experience of a single centre in the UK.
    van Hamel Parsons V; Gardner K; Patel R; Thein SL
    Ann Hematol; 2016 Jan; 95(2):227-32. PubMed ID: 26490882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hospital acquired venous thromboembolism in children with sickle cell disease.
    Agarwal S; Foster KL; Anum SJ; Shapiro MC; Han H; Scheurer ME; Airewele G; Sartain SE
    Pediatr Hematol Oncol; 2024 Oct; 41(7):459-469. PubMed ID: 38836515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease, sickle trait and the risk for venous thromboembolism: a systematic review and meta-analysis.
    Noubiap JJ; Temgoua MN; Tankeu R; Tochie JN; Wonkam A; Bigna JJ
    Thromb J; 2018; 16():27. PubMed ID: 30305805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and safety of oral anticoagulants in patients with sickle cell disease and venous thromboembolism: a retrospective cohort study.
    Roberts MZ; Gaskill GE; Kanter-Washko J; Kyle TR; Jones BC; Bohm NM
    J Thromb Thrombolysis; 2018 May; 45(4):512-515. PubMed ID: 29556958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I diagnose and treat venous thromboembolism in sickle cell disease.
    Shet AS; Wun T
    Blood; 2018 Oct; 132(17):1761-1769. PubMed ID: 29764840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism in adults with sickle cell disease: a serious and under-recognized complication.
    Naik RP; Streiff MB; Haywood C; Nelson JA; Lanzkron S
    Am J Med; 2013 May; 126(5):443-9. PubMed ID: 23582935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.